Logo.jpg
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
March 18, 2024 09:00 ET | Scilex Holding Company
ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults.1 According to market data from 2018, it...
scilogo.jpg
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
March 18, 2024 07:29 ET | SciSparc Ltd
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of...
BTAI-logo-png-220x123.png
BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
March 15, 2024 07:00 ET | BioXcel Therapeutics
NEW HAVEN, Conn., March 15, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in...
White Filament LED Bulbs
Feit Electric Announces Second Patent Enforcement Action Against Infringing White LED Filaments
March 13, 2024 16:20 ET | Feit Electric
Feit Electric Company, Inc. today commenced a second white filament patent infringement action against Savant Technologies doing business as GE Lighting
PDS Biotech Logo.png
PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
March 13, 2024 08:00 ET | PDS Biotechnology Corporation
Preclinical research published in Vaccines demonstrates Infectimune® significantly improved quantity and quality of potent multifunctional CD4 T cells compared to vaccine adjuvants Patent for...
shoals logo.jpg
Shoals Technologies Group Asserts Its Intellectual Property Rights and Vows to Defend Patent
March 12, 2024 08:00 ET | Shoals Technologies Group
PORTLAND, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc., a leading provider of electrical balance of systems (“EBOS”) solutions for solar, battery storage, and electric...
Immunovant Awarded U.S. Patent for IMVT-1402
March 12, 2024 07:30 ET | Immunovant Inc.
Composition of matter patent issued with coverage until June 2043Patent also includes methods of use and methods of manufacturing claims NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Immunovant,...
Napigen logo-full.jpg
NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
March 11, 2024 08:15 ET | Napigen, Inc.
The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1 grant.
pluri.jpg
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation
March 11, 2024 07:00 ET | Pluri Inc.
HAIFA, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- In a strategic move that underscores its innovative edge in the agtech sector, Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company") today...
scilogo.jpg
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
March 07, 2024 07:49 ET | SciSparc Ltd
The Company's most recent patent further solidifies its position, complementing existing grants in the U.S., Japan, Australia and other key jurisdictions TEL AVIV, Israel, March 07, 2024 ...